Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 99 for:    Open Studies | "Fertilization in Vitro"
Previous Study | Return to List | Next Study

Registry Study of Traditional Morphology Grading Combined With Eeva in IVF Treatment (MERGE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by Auxogyn, Inc.
Information provided by (Responsible Party):
Auxogyn, Inc. Identifier:
First received: March 20, 2013
Last updated: September 24, 2014
Last verified: September 2014

The purpose of this study is to record and evaluate the use of traditional morphology grading combined with Eeva in the treatment of in vitro fertilization.

Condition Intervention
Device: In-vitro fertilization using Eeva

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 12 Months
Official Title: MERGE: MulticEnter ReGistry With Eeva

Resource links provided by NLM:

Further study details as provided by Auxogyn, Inc.:

Primary Outcome Measures:
  • Clinical Pregnancy Rate [ Time Frame: 5-6 gestational weeks ] [ Designated as safety issue: No ]
    Determined by first pregnancy ultrasound outcome and optional 12-month phone follow-up

Other Outcome Measures:
  • Multiple Pregnancy Rate [ Time Frame: 5-6 gestational weeks ] [ Designated as safety issue: No ]
    Determined by follow-up pregnancy ultrasound outcome

  • Spontaneous Miscarriage Rate [ Time Frame: 5-6 gestational weeks ] [ Designated as safety issue: No ]
    Determined by follow-up pregnancy ultrasound outcome

Estimated Enrollment: 1200
Study Start Date: February 2013
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
In-vitro fertilization using Eeva
Patients undergoing in-vitro fertilization treatment who provide informed consent and use Eeva in their treatment cycle.
Device: In-vitro fertilization using Eeva
Eeva will image embryos through cleavage stage (Day 3). Embryologists will use Eeva results along with traditional morphological grading to assist in selecting embryo(s) for transfer or freezing.

Detailed Description:

This is a prospective, observational, single-arm, nonrandomized, multicenter study. Data will be collected to establish eligibility, at baseline, during the stimulation and in vitro fertilization process, during embryo culture, at embryo transfer, at 12-18 days post egg retrieval to verify biochemical pregnancy, and then typically at 5-6 weeks gestational weeks to verify clinical pregnancy.


Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients undergoing in vitro fertilization treatment who provide informed consent and use Eeva in their treatment cycle.


Inclusion Criteria:

  • women undergoing fresh in vitro fertilization treatment using their own eggs or donor eggs.

Exclusion Criteria:

  • history of cancer.
  • gestational carrier.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01816802

Contact: Tasha Kalista (650) 931-6732

United States, California
HRC Fertility Recruiting
Encino, California, United States, 91436
Contact: Gavin Anthony    818-788-7288 ext 244   
Principal Investigator: Michael Feinmann, MD         
Stanford Fertility and Reproductive Medicine Center Recruiting
Palo Alto, California, United States, 94304
Contact: Mariluz Suarez, MSC   
Principal Investigator: Valerie Baker, MD         
Reproductive Partners Recruiting
Redondo Beach, California, United States, 90277
Contact: Bill Yee, MD    310-318-3010      
Principal Investigator: Bill Yee, MD         
Pacific Fertility Center Recruiting
San Francisco, California, United States, 95124
Contact: Kirstin MacDougall    415-249-3638   
Principal Investigator: Philip Chenette, MD         
United States, Connecticut
Center for Advanced Reproductive Services (UCHC) Recruiting
Farmington, Connecticut, United States, 06030
Contact: Paul Verrastro    860-679-4580   
Principal Investigator: Claudio Benadiva, MD         
United States, Illinois
Northwestern Medical Faculty Foundation Recruiting
Chicago, Illinois, United States, 60611
Contact: LaShante Griffin   
Principal Investigator: Jared Robins, MD         
Fertility Centers of Illinois, Highland Park IVF Center Recruiting
Highland Park, Illinois, United States, 60035
Contact: Sue Jasulaitis, RN    312-222-8200 ext 23413   
Principal Investigator: Angeline Beltsos, MD         
United States, New York
Long Island IVF Recruiting
Melville, New York, United States, 11747
Contact: Gail Nee, NP    631-768-8797   
Principal Investigator: Daniel Kenigsberg, MD         
United States, Ohio
University Hospital Fertility Center Recruiting
Beachwood, Ohio, United States, 44122
Contact: James Goldfarb, MD    216-285-5028      
Principal Investigator: James Goldfarb, MD         
Institute for Reproductive Health Recruiting
Cincinnati, Ohio, United States, 45209
Contact: Lizzie West, RN    513-924-5577   
Principal Investigator: Michael Scheiber, MD         
United States, Texas
Fertility Center of San Antonio Recruiting
San Antonio, Texas, United States, 78229
Contact: Amy Galindo    210-692-0577   
Principal Investigator: Joesph Martin, MD         
Sponsors and Collaborators
Auxogyn, Inc.
Study Director: Shehua Shen, MD Auxogyn, Inc.
  More Information

Additional Information:
No publications provided

Responsible Party: Auxogyn, Inc. Identifier: NCT01816802     History of Changes
Other Study ID Numbers: 2012-AUX-009, TST 2193-p
Study First Received: March 20, 2013
Last Updated: September 24, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Auxogyn, Inc.:
In vitro fertilization
Assisted reproductive therapy
Time-lapse image recording
Image analysis software

Additional relevant MeSH terms:
Genital Diseases, Female
Genital Diseases, Male processed this record on November 20, 2014